Pinto-Merino, Á.; Labrador, J.; Zubiaur, P.; Alcaraz, R.; Herrero, M.J.; Montesinos, P.; Abad-Santos, F.; Saiz-Rodríguez, M.
Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives. Pharmaceutics 2022, 14, 559.
https://doi.org/10.3390/pharmaceutics14030559
AMA Style
Pinto-Merino Á, Labrador J, Zubiaur P, Alcaraz R, Herrero MJ, Montesinos P, Abad-Santos F, Saiz-Rodríguez M.
Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives. Pharmaceutics. 2022; 14(3):559.
https://doi.org/10.3390/pharmaceutics14030559
Chicago/Turabian Style
Pinto-Merino, Álvaro, Jorge Labrador, Pablo Zubiaur, Raquel Alcaraz, María José Herrero, Pau Montesinos, Francisco Abad-Santos, and Miriam Saiz-Rodríguez.
2022. "Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives" Pharmaceutics 14, no. 3: 559.
https://doi.org/10.3390/pharmaceutics14030559
APA Style
Pinto-Merino, Á., Labrador, J., Zubiaur, P., Alcaraz, R., Herrero, M. J., Montesinos, P., Abad-Santos, F., & Saiz-Rodríguez, M.
(2022). Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives. Pharmaceutics, 14(3), 559.
https://doi.org/10.3390/pharmaceutics14030559
